News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Russia First To Approve Merck KGaA Multiple Sclerosis Pill Cladribine
July 12, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FRANKFURT, July 12 (Reuters) - Russia is the first country to approve Merck KGaA's (MRCG.DE) new multiple sclerosis pill cladribine, giving the German drugmaker an edge in the emerging market against larger rival Novartis AG (NOVN.VX).
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
Europe
MORE ON THIS TOPIC
IN PARTNERSHIP WITH ELEMENT
Innovation, Resilience, and the Future of Global Manufacturing
October 30, 2025
·
1 min read
·
BioSpace Insights
Regulatory
Life-Threatening Liver Toxicity Triggers FDA Freeze on Two Intellia Gene Therapy Studies
October 30, 2025
·
2 min read
·
Tristan Manalac
Job Trends
Almost 1/3 Eyeing Job Options Outside US,
BioSpace
Finds
October 30, 2025
·
4 min read
·
Angela Gabriel
Biosimilars
FDA Proposes Lower Bar for Biosimilar Approvals in Bid To Lower Drug Prices
October 29, 2025
·
3 min read
·
Dan Samorodnitsky
